Rank | Gene Set | Z-score |
---|---|---|
1 | nuclear pore organization (GO:0006999) | 5.73061664 |
2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.60380634 |
3 | pore complex assembly (GO:0046931) | 5.00487627 |
4 | interkinetic nuclear migration (GO:0022027) | 4.93412280 |
5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.81189730 |
6 | sister chromatid cohesion (GO:0007062) | 4.01095140 |
7 | cellular response to ethanol (GO:0071361) | 4.00338599 |
8 | nucleus localization (GO:0051647) | 3.90649413 |
9 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.83762419 |
10 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.77365011 |
11 | peptidyl-lysine methylation (GO:0018022) | 3.68322054 |
12 | regulation of pigment cell differentiation (GO:0050932) | 3.67110214 |
13 | regulation of DNA endoreduplication (GO:0032875) | 3.64830076 |
14 | DNA synthesis involved in DNA repair (GO:0000731) | 3.63097407 |
15 | Golgi to endosome transport (GO:0006895) | 3.61453605 |
16 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.61180924 |
17 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.61180924 |
18 | modulation by symbiont of host immune response (GO:0052553) | 3.61180924 |
19 | positive regulation by symbiont of host defense response (GO:0052509) | 3.61180924 |
20 | modulation by symbiont of host defense response (GO:0052031) | 3.61180924 |
21 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.61180924 |
22 | histone mRNA catabolic process (GO:0071044) | 3.60081965 |
23 | regulation of RNA export from nucleus (GO:0046831) | 3.59569392 |
24 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.58986670 |
25 | negative regulation of cell killing (GO:0031342) | 3.58986670 |
26 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.57406522 |
27 | negative regulation of DNA repair (GO:0045738) | 3.56888900 |
28 | regulation of establishment of cell polarity (GO:2000114) | 3.56541927 |
29 | regulation of gamma-delta T cell activation (GO:0046643) | 3.53168474 |
30 | positive regulation of histone deacetylation (GO:0031065) | 3.51820391 |
31 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.48540400 |
32 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.47096581 |
33 | synapsis (GO:0007129) | 3.45863850 |
34 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.38878824 |
35 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.38878824 |
36 | genitalia morphogenesis (GO:0035112) | 3.35341935 |
37 | regulation of centriole replication (GO:0046599) | 3.28914269 |
38 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 3.28747697 |
39 | establishment of nucleus localization (GO:0040023) | 3.27306061 |
40 | histone H3-K9 methylation (GO:0051567) | 3.25405400 |
41 | positive regulation of developmental pigmentation (GO:0048087) | 3.21482650 |
42 | protein K48-linked deubiquitination (GO:0071108) | 3.21330408 |
43 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.21181348 |
44 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 3.20881039 |
45 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 3.20881039 |
46 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 3.20881039 |
47 | protein K11-linked deubiquitination (GO:0035871) | 3.20255032 |
48 | protein prenylation (GO:0018342) | 3.18779092 |
49 | prenylation (GO:0097354) | 3.18779092 |
50 | histone H3-K4 trimethylation (GO:0080182) | 3.18453775 |
51 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787) | 3.15231209 |
52 | histone H3-K9 modification (GO:0061647) | 3.08395060 |
53 | mitotic sister chromatid cohesion (GO:0007064) | 3.08208747 |
54 | regulation of histone H3-K9 methylation (GO:0051570) | 3.08171256 |
55 | response to muramyl dipeptide (GO:0032495) | 3.08114777 |
56 | regulation of protein polyubiquitination (GO:1902914) | 3.08037004 |
57 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.07208630 |
58 | histone lysine demethylation (GO:0070076) | 3.06497848 |
59 | * microtubule anchoring (GO:0034453) | 3.06432085 |
60 | positive thymic T cell selection (GO:0045059) | 3.05720241 |
61 | growth hormone receptor signaling pathway (GO:0060396) | 3.05636636 |
62 | centriole replication (GO:0007099) | 3.05309793 |
63 | hepatocyte apoptotic process (GO:0097284) | 3.04386412 |
64 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.02899756 |
65 | positive regulation of interferon-alpha production (GO:0032727) | 3.02223763 |
66 | histone-serine phosphorylation (GO:0035404) | 3.01739275 |
67 | NIK/NF-kappaB signaling (GO:0038061) | 3.00283233 |
68 | protein localization to Golgi apparatus (GO:0034067) | 2.98346061 |
69 | I-kappaB phosphorylation (GO:0007252) | 2.97924269 |
70 | histone demethylation (GO:0016577) | 2.97054085 |
71 | positive regulation of granulocyte differentiation (GO:0030854) | 2.95723771 |
72 | positive regulation of B cell differentiation (GO:0045579) | 2.92408884 |
73 | negative thymic T cell selection (GO:0045060) | 2.91525907 |
74 | protein K63-linked deubiquitination (GO:0070536) | 2.91457937 |
75 | negative T cell selection (GO:0043383) | 2.89881262 |
76 | negative regulation of neurotransmitter transport (GO:0051589) | 2.89515391 |
77 | establishment of protein localization to Golgi (GO:0072600) | 2.87798460 |
78 | macrophage activation involved in immune response (GO:0002281) | 2.86268298 |
79 | early endosome to late endosome transport (GO:0045022) | 2.85711116 |
80 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.85658895 |
81 | regulation of interferon-alpha production (GO:0032647) | 2.85205685 |
82 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.82975559 |
83 | snRNA transcription (GO:0009301) | 2.82429558 |
84 | neural tube formation (GO:0001841) | 2.81768782 |
85 | TOR signaling (GO:0031929) | 2.81632459 |
86 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.81313013 |
87 | protein targeting to lysosome (GO:0006622) | 2.80842074 |
88 | establishment of protein localization to vacuole (GO:0072666) | 2.80842074 |
89 | protein targeting to vacuole (GO:0006623) | 2.80842074 |
90 | regulation of centrosome duplication (GO:0010824) | 2.80130276 |
91 | centrosome duplication (GO:0051298) | 2.79832723 |
92 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.79743160 |
93 | histone H3-K9 demethylation (GO:0033169) | 2.77642217 |
94 | cellular extravasation (GO:0045123) | 2.75555220 |
95 | protein targeting to Golgi (GO:0000042) | 2.71221536 |
96 | centrosome localization (GO:0051642) | 2.70121238 |
97 | peptidyl-lysine dimethylation (GO:0018027) | 2.68666477 |
98 | regulation of histone H3-K27 methylation (GO:0061085) | 2.68626173 |
99 | positive regulation of DNA-templated transcription, initiation (GO:2000144) | 2.68385463 |
100 | positive T cell selection (GO:0043368) | 2.67133720 |
101 | natural killer cell mediated immunity (GO:0002228) | 2.67131248 |
102 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.67131248 |
103 | peptidyl-threonine phosphorylation (GO:0018107) | 2.67027140 |
104 | microtubule nucleation (GO:0007020) | 2.66653908 |
105 | nuclear pore complex assembly (GO:0051292) | 2.64791106 |
106 | nucleus organization (GO:0006997) | 2.64693221 |
107 | N-terminal protein amino acid acetylation (GO:0006474) | 2.62029315 |
108 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.61224546 |
109 | T cell migration (GO:0072678) | 2.61145845 |
110 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.59813625 |
111 | regulation of necroptotic process (GO:0060544) | 2.58631302 |
112 | labyrinthine layer development (GO:0060711) | 2.58264569 |
113 | nerve growth factor signaling pathway (GO:0038180) | 2.57988555 |
114 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.57544486 |
115 | cellular response to growth hormone stimulus (GO:0071378) | 2.57435179 |
116 | chromosome organization involved in meiosis (GO:0070192) | 2.56470827 |
117 | oocyte development (GO:0048599) | 2.55580383 |
118 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.55553201 |
119 | peptidyl-threonine modification (GO:0018210) | 2.54054113 |
120 | histone H3-K4 methylation (GO:0051568) | 2.53596657 |
121 | response to type I interferon (GO:0034340) | 2.53259045 |
122 | protein dealkylation (GO:0008214) | 2.52946848 |
123 | protein demethylation (GO:0006482) | 2.52946848 |
124 | T cell selection (GO:0045058) | 2.52202704 |
125 | histone H3-K36 demethylation (GO:0070544) | 2.51909981 |
126 | response to host immune response (GO:0052572) | 2.51462746 |
127 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.51462746 |
128 | protein deubiquitination (GO:0016579) | 2.51419513 |
129 | regulation of protein glycosylation (GO:0060049) | 2.48892162 |
130 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 2.46423485 |
131 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 2.46423485 |
132 | thymic T cell selection (GO:0045061) | 2.46125007 |
133 | histone H4-K16 acetylation (GO:0043984) | 2.45308200 |
134 | pericardium development (GO:0060039) | 2.43950835 |
135 | cellular response to type I interferon (GO:0071357) | 2.42863835 |
136 | type I interferon signaling pathway (GO:0060337) | 2.42863835 |
137 | regulation of B cell differentiation (GO:0045577) | 2.41426450 |
138 | mature B cell differentiation (GO:0002335) | 2.41334873 |
139 | necroptotic process (GO:0070266) | 2.41072235 |
140 | NLS-bearing protein import into nucleus (GO:0006607) | 2.41070094 |
141 | macroautophagy (GO:0016236) | 2.40079968 |
142 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.39685611 |
143 | response to host (GO:0075136) | 2.39685611 |
144 | response to host defenses (GO:0052200) | 2.39685611 |
145 | phospholipid homeostasis (GO:0055091) | 2.39494217 |
146 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.37874943 |
147 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.37874943 |
148 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.37874943 |
149 | regulation of RIG-I signaling pathway (GO:0039535) | 2.37442486 |
150 | acrosome assembly (GO:0001675) | 2.36626153 |
151 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.36529242 |
152 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.36042493 |
153 | corticosteroid receptor signaling pathway (GO:0031958) | 2.35971793 |
154 | lipid translocation (GO:0034204) | 2.35759945 |
155 | phospholipid translocation (GO:0045332) | 2.35759945 |
156 | negative regulation of granulocyte differentiation (GO:0030853) | 2.34064795 |
157 | peptidyl-lysine trimethylation (GO:0018023) | 2.33933145 |
158 | natural killer cell differentiation (GO:0001779) | 2.33931679 |
159 | striated muscle atrophy (GO:0014891) | 2.32310823 |
160 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.31708982 |
161 | positive regulation of protein deacetylation (GO:0090312) | 2.31309237 |
162 | definitive hemopoiesis (GO:0060216) | 2.29933272 |
163 | regulation of T cell tolerance induction (GO:0002664) | 2.28159729 |
164 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.27192975 |
165 | histone lysine methylation (GO:0034968) | 2.25870963 |
166 | neutrophil activation (GO:0042119) | 2.25686254 |
167 | B cell homeostasis (GO:0001782) | 2.25217921 |
168 | regulation of mRNA catabolic process (GO:0061013) | 2.25089480 |
169 | pre-miRNA processing (GO:0031054) | 2.24671290 |
170 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.23644767 |
171 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.23644767 |
172 | regulation of histone deacetylation (GO:0031063) | 2.20824041 |
173 | negative regulation of histone methylation (GO:0031061) | 2.20653750 |
174 | seminiferous tubule development (GO:0072520) | 2.20136710 |
175 | positive regulation of interferon-beta production (GO:0032728) | 2.19390975 |
176 | necrotic cell death (GO:0070265) | 2.19024839 |
177 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.18721336 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.25784533 |
2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.22414702 |
3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.99358994 |
4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.15436728 |
5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.02651133 |
6 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.91266194 |
7 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.87832698 |
8 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.76481277 |
9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.76244767 |
10 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.66688226 |
11 | GATA1_22025678_ChIP-Seq_K562_Human | 2.55817848 |
12 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.55395385 |
13 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.51273562 |
14 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.51236724 |
15 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.48859744 |
16 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.37600090 |
17 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.31750140 |
18 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.31109299 |
19 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.30705040 |
20 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.23155152 |
21 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.22370535 |
22 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.21772804 |
23 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.18688143 |
24 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.16742502 |
25 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.09047058 |
26 | FUS_26573619_Chip-Seq_HEK293_Human | 2.04707683 |
27 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.94934739 |
28 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.81458271 |
29 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.79528146 |
30 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.77128805 |
31 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.77051526 |
32 | SPI1_23127762_ChIP-Seq_K562_Human | 1.76878758 |
33 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.76276290 |
34 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.74292565 |
35 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.70505239 |
36 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.69160625 |
37 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.68110990 |
38 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.67222008 |
39 | * MYB_26560356_Chip-Seq_TH2_Human | 1.65780645 |
40 | EWS_26573619_Chip-Seq_HEK293_Human | 1.61969062 |
41 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.61906400 |
42 | * MYB_26560356_Chip-Seq_TH1_Human | 1.59100701 |
43 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.57207426 |
44 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.56403807 |
45 | P300_19829295_ChIP-Seq_ESCs_Human | 1.55845693 |
46 | MAF_26560356_Chip-Seq_TH1_Human | 1.54241245 |
47 | TCF4_23295773_ChIP-Seq_U87_Human | 1.54210861 |
48 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.52016642 |
49 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.48590920 |
50 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.47203278 |
51 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.46267771 |
52 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.46109745 |
53 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.45739226 |
54 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.45085138 |
55 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.44328169 |
56 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.43559160 |
57 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.43306287 |
58 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.43218083 |
59 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.42553608 |
60 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.41884414 |
61 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.41848203 |
62 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.41429311 |
63 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.41151903 |
64 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.39454482 |
65 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.38494309 |
66 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.37424532 |
67 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.36509275 |
68 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.35036336 |
69 | MYC_22102868_ChIP-Seq_BL_Human | 1.34592395 |
70 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.34502044 |
71 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.31422962 |
72 | UTX_26944678_Chip-Seq_JUKART_Human | 1.29246968 |
73 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.28893966 |
74 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.28687535 |
75 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.28687535 |
76 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.28134290 |
77 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.25972513 |
78 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.25727911 |
79 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.25675602 |
80 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25186960 |
81 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.25092522 |
82 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.24908477 |
83 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24535878 |
84 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.23926654 |
85 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.23821178 |
86 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.23256975 |
87 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.22236371 |
88 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.21428310 |
89 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.20829849 |
90 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20813897 |
91 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20805208 |
92 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.20685995 |
93 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.20215639 |
94 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.19974666 |
95 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.19168428 |
96 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.19108296 |
97 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.19060194 |
98 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.18063179 |
99 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.17816752 |
100 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.17659203 |
101 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.17467551 |
102 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.17418536 |
103 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.17378579 |
104 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.17035081 |
105 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.16642643 |
106 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.16475511 |
107 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.16215192 |
108 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.15492851 |
109 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.14982522 |
110 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.14595535 |
111 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.13105804 |
112 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.13051495 |
113 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.12846423 |
114 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.12800840 |
115 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.12450587 |
116 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.12148205 |
117 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.12042455 |
118 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.11340803 |
119 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.10946135 |
120 | * P300_18555785_Chip-Seq_ESCs_Mouse | 1.09589295 |
121 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.09329505 |
122 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09044061 |
123 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.08825973 |
124 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.08263792 |
125 | GATA1_19941826_ChIP-Seq_K562_Human | 1.07489517 |
126 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.07450497 |
127 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.05882695 |
128 | * OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.05152088 |
129 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.04839757 |
130 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.04594902 |
131 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.03780942 |
132 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.01328477 |
133 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.01328477 |
134 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.00778875 |
135 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.00347920 |
136 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.00086071 |
137 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.99801638 |
138 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.99348181 |
139 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98929350 |
140 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.97418141 |
141 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.96021200 |
142 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.94363283 |
143 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.93399132 |
144 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.93358172 |
145 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.92483037 |
146 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.91818520 |
147 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.90723414 |
148 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90486554 |
149 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.90040463 |
150 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.89693015 |
151 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.88867093 |
152 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.87968040 |
153 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87660893 |
154 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.86294115 |
155 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.85973861 |
156 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85198398 |
157 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.84965141 |
158 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.83386564 |
159 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.83032229 |
160 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.82415401 |
161 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.81988004 |
162 | TP53_16413492_ChIP-PET_HCT116_Human | 0.80616026 |
163 | * FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.77873639 |
164 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.77849898 |
165 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.77793977 |
166 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.77793977 |
167 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.77061293 |
168 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.77061293 |
169 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.76466251 |
170 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.76456151 |
171 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.76335741 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0000569_abnormal_digit_pigmentation | 5.73792602 |
2 | MP0003300_gastrointestinal_ulcer | 3.42873584 |
3 | MP0001835_abnormal_antigen_presentation | 3.02708732 |
4 | MP0002166_altered_tumor_susceptibility | 2.90423329 |
5 | MP0008877_abnormal_DNA_methylation | 2.78617854 |
6 | MP0000685_abnormal_immune_system | 2.39624849 |
7 | MP0001800_abnormal_humoral_immune | 2.31939039 |
8 | MP0004510_myositis | 2.28853458 |
9 | MP0003890_abnormal_embryonic-extraembry | 2.28366939 |
10 | MP0002006_tumorigenesis | 2.25588571 |
11 | MP0005076_abnormal_cell_differentiation | 2.25586076 |
12 | MP0003436_decreased_susceptibility_to | 2.25382759 |
13 | MP0005387_immune_system_phenotype | 2.24666165 |
14 | MP0001790_abnormal_immune_system | 2.24666165 |
15 | MP0003646_muscle_fatigue | 2.17469390 |
16 | MP0002396_abnormal_hematopoietic_system | 2.08033505 |
17 | MP0002452_abnormal_antigen_presenting | 2.01986655 |
18 | MP0010678_abnormal_skin_adnexa | 2.01285324 |
19 | MP0004808_abnormal_hematopoietic_stem | 2.01106310 |
20 | MP0009278_abnormal_bone_marrow | 2.01003380 |
21 | MP0003303_peritoneal_inflammation | 2.00651803 |
22 | MP0003045_fibrosis | 1.94389282 |
23 | MP0005671_abnormal_response_to | 1.93168821 |
24 | MP0005464_abnormal_platelet_physiology | 1.91706770 |
25 | MP0002419_abnormal_innate_immunity | 1.90229546 |
26 | MP0000383_abnormal_hair_follicle | 1.89912529 |
27 | MP0002723_abnormal_immune_serum | 1.88174199 |
28 | MP0000427_abnormal_hair_cycle | 1.86944688 |
29 | MP0005174_abnormal_tail_pigmentation | 1.83882548 |
30 | MP0005000_abnormal_immune_tolerance | 1.81022219 |
31 | MP0004947_skin_inflammation | 1.79721269 |
32 | MP0005025_abnormal_response_to | 1.78296662 |
33 | MP0010352_gastrointestinal_tract_polyps | 1.77825892 |
34 | MP0001819_abnormal_immune_cell | 1.75550229 |
35 | MP0002420_abnormal_adaptive_immunity | 1.75073746 |
36 | MP0002398_abnormal_bone_marrow | 1.73736677 |
37 | MP0003183_abnormal_peptide_metabolism | 1.72536801 |
38 | MP0001873_stomach_inflammation | 1.69592800 |
39 | MP0003763_abnormal_thymus_physiology | 1.68189064 |
40 | MP0003950_abnormal_plasma_membrane | 1.67710345 |
41 | MP0010155_abnormal_intestine_physiology | 1.67610110 |
42 | MP0004381_abnormal_hair_follicle | 1.67555209 |
43 | MP0010307_abnormal_tumor_latency | 1.64748001 |
44 | MP0009785_altered_susceptibility_to | 1.61981216 |
45 | MP0005409_darkened_coat_color | 1.60857918 |
46 | MP0010094_abnormal_chromosome_stability | 1.59492283 |
47 | MP0001545_abnormal_hematopoietic_system | 1.58323434 |
48 | MP0005397_hematopoietic_system_phenotyp | 1.58323434 |
49 | MP0000371_diluted_coat_color | 1.56280380 |
50 | MP0003252_abnormal_bile_duct | 1.55698274 |
51 | MP0000716_abnormal_immune_system | 1.50733543 |
52 | MP0002009_preneoplasia | 1.48000722 |
53 | MP0003172_abnormal_lysosome_physiology | 1.46749578 |
54 | MP0002254_reproductive_system_inflammat | 1.45922816 |
55 | MP0005410_abnormal_fertilization | 1.43620449 |
56 | MP0003656_abnormal_erythrocyte_physiolo | 1.40576257 |
57 | MP0002148_abnormal_hypersensitivity_rea | 1.39297728 |
58 | MP0002405_respiratory_system_inflammati | 1.37861178 |
59 | MP0004264_abnormal_extraembryonic_tissu | 1.37286225 |
60 | MP0002928_abnormal_bile_duct | 1.36224806 |
61 | MP0008961_abnormal_basal_metabolism | 1.30593953 |
62 | MP0005058_abnormal_lysosome_morphology | 1.27461538 |
63 | MP0003077_abnormal_cell_cycle | 1.27280748 |
64 | MP0004130_abnormal_muscle_cell | 1.27240173 |
65 | MP0001845_abnormal_inflammatory_respons | 1.26740956 |
66 | MP0000703_abnormal_thymus_morphology | 1.25793067 |
67 | MP0003868_abnormal_feces_composition | 1.24557792 |
68 | MP0000372_irregular_coat_pigmentation | 1.24121216 |
69 | MP0008058_abnormal_DNA_repair | 1.20479377 |
70 | MP0002722_abnormal_immune_system | 1.19952238 |
71 | MP0005408_hypopigmentation | 1.19826962 |
72 | MP0002429_abnormal_blood_cell | 1.19509300 |
73 | MP0001661_extended_life_span | 1.19195039 |
74 | MP0000689_abnormal_spleen_morphology | 1.18453802 |
75 | MP0002138_abnormal_hepatobiliary_system | 1.17588965 |
76 | MP0003091_abnormal_cell_migration | 1.16388800 |
77 | MP0002877_abnormal_melanocyte_morpholog | 1.14115687 |
78 | MP0005310_abnormal_salivary_gland | 1.13874817 |
79 | MP0003705_abnormal_hypodermis_morpholog | 1.10693181 |
80 | MP0004134_abnormal_chest_morphology | 1.10421819 |
81 | MP0001533_abnormal_skeleton_physiology | 1.08670007 |
82 | MP0006082_CNS_inflammation | 1.08327440 |
83 | MP0003566_abnormal_cell_adhesion | 1.08260030 |
84 | MP0009697_abnormal_copulation | 1.08228396 |
85 | MP0002998_abnormal_bone_remodeling | 1.07977558 |
86 | MP0005187_abnormal_penis_morphology | 1.05124572 |
87 | MP0005379_endocrine/exocrine_gland_phen | 1.04784838 |
88 | MP0003121_genomic_imprinting | 1.03271649 |
89 | MP0001853_heart_inflammation | 1.02937446 |
90 | MP0003866_abnormal_defecation | 1.02173005 |
91 | MP0003724_increased_susceptibility_to | 1.01257412 |
92 | MP0009703_decreased_birth_body | 1.01111523 |
93 | MP0004036_abnormal_muscle_relaxation | 0.96963232 |
94 | MP0005666_abnormal_adipose_tissue | 0.96702896 |
95 | MP0005220_abnormal_exocrine_pancreas | 0.95937351 |
96 | MP0004185_abnormal_adipocyte_glucose | 0.95472338 |
97 | MP0000733_abnormal_muscle_development | 0.94790370 |
98 | MP0010234_abnormal_vibrissa_follicle | 0.94755550 |
99 | MP0002088_abnormal_embryonic_growth/wei | 0.93712809 |
100 | MP0003191_abnormal_cellular_cholesterol | 0.93597252 |
101 | MP0003984_embryonic_growth_retardation | 0.92409448 |
102 | MP0005670_abnormal_white_adipose | 0.92308187 |
103 | MP0000015_abnormal_ear_pigmentation | 0.91660852 |
104 | MP0008469_abnormal_protein_level | 0.90983568 |
105 | MP0003448_altered_tumor_morphology | 0.90880322 |
106 | MP0005266_abnormal_metabolism | 0.89699202 |
107 | MP0001851_eye_inflammation | 0.89124333 |
108 | MP0005375_adipose_tissue_phenotype | 0.86986789 |
109 | MP0003787_abnormal_imprinting | 0.85874534 |
110 | MP0000003_abnormal_adipose_tissue | 0.85278289 |
111 | MP0006054_spinal_hemorrhage | 0.85201333 |
112 | MP0009764_decreased_sensitivity_to | 0.84384695 |
113 | MP0004484_altered_response_of | 0.83953016 |
114 | MP0000428_abnormal_craniofacial_morphol | 0.82931213 |
115 | MP0009115_abnormal_fat_cell | 0.82891130 |
116 | MP0000013_abnormal_adipose_tissue | 0.82843235 |
117 | MP0002086_abnormal_extraembryonic_tissu | 0.82712504 |
118 | MP0001929_abnormal_gametogenesis | 0.82574213 |
119 | MP0003828_pulmonary_edema | 0.81845127 |
120 | MP0010630_abnormal_cardiac_muscle | 0.77671543 |
121 | MP0008057_abnormal_DNA_replication | 0.77461694 |
122 | MP0002971_abnormal_brown_adipose | 0.75720757 |
123 | MP0003111_abnormal_nucleus_morphology | 0.75679051 |
124 | MP0004084_abnormal_cardiac_muscle | 0.75495034 |
125 | MP0005360_urolithiasis | 0.74720296 |
126 | MP0000609_abnormal_liver_physiology | 0.74621898 |
127 | MP0003221_abnormal_cardiomyocyte_apopto | 0.74400224 |
128 | MP0000465_gastrointestinal_hemorrhage | 0.73410511 |
129 | MP0001697_abnormal_embryo_size | 0.73130728 |
130 | MP0009763_increased_sensitivity_to | 0.72717262 |
131 | MP0002084_abnormal_developmental_patter | 0.72643125 |
132 | MP0000377_abnormal_hair_follicle | 0.71475505 |
133 | MP0003943_abnormal_hepatobiliary_system | 0.71214666 |
134 | MP0002075_abnormal_coat/hair_pigmentati | 0.70618116 |
135 | MP0001672_abnormal_embryogenesis/_devel | 0.69353808 |
136 | MP0005380_embryogenesis_phenotype | 0.69353808 |
137 | MP0002837_dystrophic_cardiac_calcinosis | 0.69183249 |
138 | MP0005171_absent_coat_pigmentation | 0.69166154 |
139 | MP0000858_altered_metastatic_potential | 0.68304085 |
140 | MP0008007_abnormal_cellular_replicative | 0.66998717 |
141 | MP0000647_abnormal_sebaceous_gland | 0.66115042 |
142 | MP0001879_abnormal_lymphatic_vessel | 0.65856543 |
143 | MP0003698_abnormal_male_reproductive | 0.65694468 |
144 | MP0003935_abnormal_craniofacial_develop | 0.65387797 |
145 | MP0005334_abnormal_fat_pad | 0.64740283 |
146 | MP0002168_other_aberrant_phenotype | 0.63460201 |
147 | MP0002332_abnormal_exercise_endurance | 0.63231284 |
148 | MP0005248_abnormal_Harderian_gland | 0.63139480 |
149 | MP0005075_abnormal_melanosome_morpholog | 0.61867511 |
150 | MP0003937_abnormal_limbs/digits/tail_de | 0.61175672 |
151 | MP0002095_abnormal_skin_pigmentation | 0.60520130 |
152 | MP0001915_intracranial_hemorrhage | 0.59341577 |
153 | MP0001186_pigmentation_phenotype | 0.59220373 |
154 | MP0005367_renal/urinary_system_phenotyp | 0.58884795 |
155 | MP0000516_abnormal_urinary_system | 0.58884795 |
156 | MP0001191_abnormal_skin_condition | 0.58844645 |
157 | MP0005621_abnormal_cell_physiology | 0.58833808 |
158 | MP0002210_abnormal_sex_determination | 0.58095807 |
159 | MP0004145_abnormal_muscle_electrophysio | 0.58073698 |
160 | MP0002163_abnormal_gland_morphology | 0.56958817 |
161 | MP0004197_abnormal_fetal_growth/weight/ | 0.56579710 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of the fingertips (HP:0001211) | 4.11737277 |
2 | Absent frontal sinuses (HP:0002688) | 3.62343325 |
3 | Thyroid carcinoma (HP:0002890) | 3.41285380 |
4 | Recurrent viral infections (HP:0004429) | 3.38173127 |
5 | Chromsome breakage (HP:0040012) | 3.31407690 |
6 | Recurrent bacterial skin infections (HP:0005406) | 3.19366239 |
7 | Autoimmune thrombocytopenia (HP:0001973) | 3.16975810 |
8 | Nasal polyposis (HP:0100582) | 3.11535841 |
9 | Recurrent fungal infections (HP:0002841) | 3.10072498 |
10 | Fair hair (HP:0002286) | 3.02762442 |
11 | Periodontitis (HP:0000704) | 3.02702922 |
12 | Sandal gap (HP:0001852) | 3.02574782 |
13 | Recurrent abscess formation (HP:0002722) | 2.91575739 |
14 | Rhabdomyosarcoma (HP:0002859) | 2.88554304 |
15 | Eczematoid dermatitis (HP:0000976) | 2.85375564 |
16 | Abnormality of chromosome stability (HP:0003220) | 2.84426263 |
17 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.83577791 |
18 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.83151103 |
19 | Macroorchidism (HP:0000053) | 2.77804605 |
20 | Frequent falls (HP:0002359) | 2.75217337 |
21 | Hepatoblastoma (HP:0002884) | 2.73551876 |
22 | Volvulus (HP:0002580) | 2.72112616 |
23 | Hyperventilation (HP:0002883) | 2.69965175 |
24 | Medulloblastoma (HP:0002885) | 2.69147540 |
25 | Short chin (HP:0000331) | 2.68709649 |
26 | Recurrent bronchitis (HP:0002837) | 2.68228814 |
27 | Curly hair (HP:0002212) | 2.64792035 |
28 | Abnormality of the ischium (HP:0003174) | 2.61159669 |
29 | Cystic hygroma (HP:0000476) | 2.60114566 |
30 | Deep philtrum (HP:0002002) | 2.55249008 |
31 | Colitis (HP:0002583) | 2.54480045 |
32 | Cerebral aneurysm (HP:0004944) | 2.52813549 |
33 | Abnormality of the nasal mucosa (HP:0000433) | 2.52585966 |
34 | Protruding tongue (HP:0010808) | 2.50226176 |
35 | Abnormal pancreas size (HP:0012094) | 2.49948402 |
36 | Long clavicles (HP:0000890) | 2.49798071 |
37 | Generalized hypopigmentation of hair (HP:0011358) | 2.49317121 |
38 | Blue irides (HP:0000635) | 2.47856230 |
39 | Hematochezia (HP:0002573) | 2.47598659 |
40 | Subaortic stenosis (HP:0001682) | 2.46005574 |
41 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.46005574 |
42 | Low anterior hairline (HP:0000294) | 2.45743619 |
43 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.44730429 |
44 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.44546534 |
45 | Arterial thrombosis (HP:0004420) | 2.44256932 |
46 | Thyroiditis (HP:0100646) | 2.42258443 |
47 | Submucous cleft hard palate (HP:0000176) | 2.39634792 |
48 | Myositis (HP:0100614) | 2.38832225 |
49 | Inflammation of the large intestine (HP:0002037) | 2.38815612 |
50 | Widely spaced teeth (HP:0000687) | 2.38791954 |
51 | Abnormality of the frontal sinuses (HP:0002687) | 2.37673113 |
52 | Tubulointerstitial nephritis (HP:0001970) | 2.36679487 |
53 | Acute myeloid leukemia (HP:0004808) | 2.35111889 |
54 | Gaze-evoked nystagmus (HP:0000640) | 2.33759965 |
55 | Neoplasm of the adrenal cortex (HP:0100641) | 2.32276800 |
56 | Neonatal hypoglycemia (HP:0001998) | 2.31160144 |
57 | Neoplasm of striated muscle (HP:0009728) | 2.31064556 |
58 | Gingival bleeding (HP:0000225) | 2.29767131 |
59 | Hyperkalemia (HP:0002153) | 2.29456503 |
60 | Embryonal renal neoplasm (HP:0011794) | 2.29214449 |
61 | Spondylolisthesis (HP:0003302) | 2.27865532 |
62 | Difficulty running (HP:0009046) | 2.27529189 |
63 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.27040068 |
64 | Long eyelashes (HP:0000527) | 2.27020292 |
65 | T lymphocytopenia (HP:0005403) | 2.26446166 |
66 | Optic neuritis (HP:0100653) | 2.25778120 |
67 | Retrobulbar optic neuritis (HP:0100654) | 2.25778120 |
68 | Narrow palate (HP:0000189) | 2.25499026 |
69 | Abnormality of T cell number (HP:0011839) | 2.25180963 |
70 | Gastrointestinal inflammation (HP:0004386) | 2.23954739 |
71 | Syringomyelia (HP:0003396) | 2.23400150 |
72 | Spinal cord lesions (HP:0100561) | 2.23400150 |
73 | Gingivitis (HP:0000230) | 2.22631020 |
74 | Recurrent cutaneous fungal infections (HP:0011370) | 2.22548928 |
75 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.22548928 |
76 | Hypoplastic ischia (HP:0003175) | 2.20188143 |
77 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.20146464 |
78 | Absent/shortened dynein arms (HP:0200106) | 2.20146464 |
79 | Abnormal hair whorl (HP:0010721) | 2.19592696 |
80 | Hypoplastic iliac wings (HP:0002866) | 2.18261539 |
81 | Truncal obesity (HP:0001956) | 2.18020059 |
82 | Hip dysplasia (HP:0001385) | 2.17722112 |
83 | Cellulitis (HP:0100658) | 2.17106952 |
84 | Acanthocytosis (HP:0001927) | 2.16114504 |
85 | Conjunctival telangiectasia (HP:0000524) | 2.15636277 |
86 | Chronic diarrhea (HP:0002028) | 2.14261083 |
87 | Orchitis (HP:0100796) | 2.13994976 |
88 | Recurrent skin infections (HP:0001581) | 2.13484343 |
89 | Vasculitis (HP:0002633) | 2.12927953 |
90 | Hypoplastic labia majora (HP:0000059) | 2.12548803 |
91 | Neoplasm of the small intestine (HP:0100833) | 2.10901969 |
92 | Urethral obstruction (HP:0000796) | 2.10869617 |
93 | Transitional cell carcinoma of the bladder (HP:0006740) | 2.10109335 |
94 | Dysmetric saccades (HP:0000641) | 2.09904134 |
95 | Bladder neoplasm (HP:0009725) | 2.09849864 |
96 | Bladder carcinoma (HP:0002862) | 2.09849864 |
97 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 2.08169268 |
98 | Overgrowth (HP:0001548) | 2.08078502 |
99 | Heterotopia (HP:0002282) | 2.07960475 |
100 | Abnormality of the astrocytes (HP:0100707) | 2.07720429 |
101 | Astrocytoma (HP:0009592) | 2.07720429 |
102 | Myocardial infarction (HP:0001658) | 2.07706033 |
103 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.07362535 |
104 | Osteolytic defects of the hand bones (HP:0009699) | 2.07362535 |
105 | Subacute progressive viral hepatitis (HP:0006572) | 2.06613833 |
106 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.06055041 |
107 | Acute lymphatic leukemia (HP:0006721) | 2.04978058 |
108 | Fatigue (HP:0012378) | 2.04525399 |
109 | Biliary tract neoplasm (HP:0100574) | 2.04206427 |
110 | Abnormality of the labia majora (HP:0012881) | 2.02183584 |
111 | Menstrual irregularities (HP:0000858) | 2.01503313 |
112 | Mediastinal lymphadenopathy (HP:0100721) | 1.99572842 |
113 | Chronic hepatic failure (HP:0100626) | 1.98400532 |
114 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.93727313 |
115 | Disinhibition (HP:0000734) | 1.92405154 |
116 | Hypoplasia of the thymus (HP:0000778) | 1.91939167 |
117 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.91352814 |
118 | Glioma (HP:0009733) | 1.90734073 |
119 | Eosinophilia (HP:0001880) | 1.89744962 |
120 | Osteomyelitis (HP:0002754) | 1.89366149 |
121 | Pulmonary infiltrates (HP:0002113) | 1.88490083 |
122 | Aortic aneurysm (HP:0004942) | 1.87526009 |
123 | Bronchitis (HP:0012387) | 1.87289460 |
124 | Prominent nose (HP:0000448) | 1.85332517 |
125 | Pigmentary retinal degeneration (HP:0001146) | 1.84349736 |
126 | Recurrent sinusitis (HP:0011108) | 1.83669614 |
127 | Cafe-au-lait spot (HP:0000957) | 1.81643231 |
128 | Hyperacusis (HP:0010780) | 1.81113437 |
129 | Overlapping toe (HP:0001845) | 1.80905627 |
130 | Oligodactyly (hands) (HP:0001180) | 1.80436243 |
131 | Cubitus valgus (HP:0002967) | 1.80171624 |
132 | Vertebral arch anomaly (HP:0008438) | 1.79791676 |
133 | Neoplasm of the oral cavity (HP:0100649) | 1.79020093 |
134 | Abnormality of chromosome segregation (HP:0002916) | 1.78625721 |
135 | Gastrointestinal carcinoma (HP:0002672) | 1.77001071 |
136 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.77001071 |
137 | Prostate neoplasm (HP:0100787) | 1.76943391 |
138 | Premature loss of primary teeth (HP:0006323) | 1.75940528 |
139 | Aqueductal stenosis (HP:0002410) | 1.75874524 |
140 | Neoplasm of the thyroid gland (HP:0100031) | 1.75410751 |
141 | Thick nail (HP:0001805) | 1.75056927 |
142 | Tapered finger (HP:0001182) | 1.74661988 |
143 | Chest pain (HP:0100749) | 1.74601759 |
144 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.74594895 |
145 | Agammaglobulinemia (HP:0004432) | 1.74249636 |
146 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.72943961 |
147 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.72943961 |
148 | Drooling (HP:0002307) | 1.72817556 |
149 | Elfin facies (HP:0004428) | 1.71409263 |
150 | IgA deficiency (HP:0002720) | 1.70970865 |
151 | Clubbing of toes (HP:0100760) | 1.70867284 |
152 | Leukocytosis (HP:0001974) | 1.70653928 |
153 | Febrile seizures (HP:0002373) | 1.70511042 |
154 | Genetic anticipation (HP:0003743) | 1.70446134 |
155 | Abnormal biliary tract morphology (HP:0012440) | 1.69770628 |
156 | Hamartoma (HP:0010566) | 1.69757160 |
157 | Large earlobe (HP:0009748) | 1.69738722 |
158 | B lymphocytopenia (HP:0010976) | 1.69278776 |
159 | Abnormality of B cell number (HP:0010975) | 1.69278776 |
160 | Lip pit (HP:0100267) | 1.66573879 |
161 | Thick eyebrow (HP:0000574) | 1.66065096 |
162 | Papillary thyroid carcinoma (HP:0002895) | 1.65624915 |
163 | Mitral stenosis (HP:0001718) | 1.63166179 |
164 | Abnormality of T cells (HP:0002843) | 1.62371713 |
165 | Meningitis (HP:0001287) | 1.61903431 |
166 | Viral hepatitis (HP:0006562) | 1.61332027 |
167 | Spontaneous hematomas (HP:0007420) | 1.61314896 |
168 | Obsessive-compulsive behavior (HP:0000722) | 1.60748509 |
169 | Lymphopenia (HP:0001888) | 1.60304528 |
170 | Coarse hair (HP:0002208) | 1.60290432 |
171 | Increased IgE level (HP:0003212) | 1.59718398 |
172 | Cutis marmorata (HP:0000965) | 1.59184994 |
173 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.58704263 |
174 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.57267095 |
175 | Panhypogammaglobulinemia (HP:0003139) | 1.57173388 |
176 | Bronchiectasis (HP:0002110) | 1.56841586 |
Rank | Gene Set | Z-score |
---|---|---|
1 | CDK12 | 3.38568779 |
2 | AKT3 | 3.23850520 |
3 | ACVR1B | 2.68735424 |
4 | MAP4K1 | 2.62098932 |
5 | CAMK1D | 2.45142832 |
6 | CAMK1G | 2.44075107 |
7 | TYK2 | 2.38872282 |
8 | RIPK1 | 2.36749620 |
9 | MAP3K14 | 2.28007141 |
10 | IKBKE | 2.24748069 |
11 | JAK1 | 2.24553181 |
12 | NLK | 2.23566674 |
13 | MAP3K10 | 2.12095802 |
14 | JAK3 | 2.09202812 |
15 | TAOK3 | 2.07927036 |
16 | FGFR3 | 1.91413429 |
17 | PNCK | 1.86773168 |
18 | STK38L | 1.82148182 |
19 | BMPR1B | 1.80322581 |
20 | OBSCN | 1.78952471 |
21 | CASK | 1.65877604 |
22 | TBK1 | 1.65569112 |
23 | PTK6 | 1.62434556 |
24 | FRK | 1.57821525 |
25 | TXK | 1.54221512 |
26 | PIK3CG | 1.50988773 |
27 | TNIK | 1.50174996 |
28 | INSRR | 1.45361077 |
29 | TTN | 1.44062427 |
30 | RIPK4 | 1.41932907 |
31 | IKBKB | 1.41166867 |
32 | NUAK1 | 1.38344328 |
33 | MAP3K13 | 1.37953947 |
34 | DMPK | 1.37318489 |
35 | EIF2AK3 | 1.35845543 |
36 | STK3 | 1.35500396 |
37 | FGFR4 | 1.34786053 |
38 | YES1 | 1.34679839 |
39 | CHUK | 1.34201368 |
40 | SGK3 | 1.30887403 |
41 | IRAK4 | 1.29749418 |
42 | SIK1 | 1.29637092 |
43 | MAP3K4 | 1.29121715 |
44 | KIT | 1.22165473 |
45 | EEF2K | 1.19943740 |
46 | BRD4 | 1.18060467 |
47 | ZAP70 | 1.17530698 |
48 | SIK2 | 1.17298418 |
49 | CSK | 1.16301900 |
50 | ERN1 | 1.14240621 |
51 | CSF1R | 1.13047399 |
52 | ITK | 1.12011197 |
53 | CDK6 | 1.11514372 |
54 | TGFBR2 | 1.11352487 |
55 | PDGFRB | 1.11255852 |
56 | HCK | 1.10994394 |
57 | MKNK2 | 1.08006251 |
58 | LATS1 | 1.05442306 |
59 | NEK6 | 1.02345665 |
60 | STK10 | 1.01790257 |
61 | JAK2 | 0.99371747 |
62 | TRIB3 | 0.97193502 |
63 | PKN2 | 0.96354960 |
64 | SGK2 | 0.95059891 |
65 | CDK9 | 0.94713506 |
66 | WNK1 | 0.94463314 |
67 | ERBB3 | 0.94179734 |
68 | MTOR | 0.93836640 |
69 | STK4 | 0.92180156 |
70 | BRSK2 | 0.90315143 |
71 | KSR1 | 0.89177354 |
72 | SGK494 | 0.88426983 |
73 | SGK223 | 0.88426983 |
74 | SYK | 0.88115150 |
75 | BTK | 0.86541658 |
76 | EPHB1 | 0.86355298 |
77 | PRKAA2 | 0.86162539 |
78 | TRPM7 | 0.84810977 |
79 | PLK4 | 0.84683122 |
80 | HIPK2 | 0.81854585 |
81 | RPS6KA4 | 0.80404325 |
82 | LCK | 0.79881202 |
83 | STK39 | 0.79493051 |
84 | NEK9 | 0.76979091 |
85 | MAP3K7 | 0.76852786 |
86 | TEC | 0.75143535 |
87 | BMPR2 | 0.75042662 |
88 | PIK3CA | 0.74697406 |
89 | NTRK3 | 0.73969081 |
90 | BLK | 0.73309631 |
91 | RET | 0.72742253 |
92 | PDK1 | 0.71461123 |
93 | IRAK1 | 0.70628704 |
94 | STK11 | 0.69939515 |
95 | NEK2 | 0.69661455 |
96 | PIM1 | 0.69407066 |
97 | ICK | 0.67113886 |
98 | RPS6KB1 | 0.66708639 |
99 | CDC7 | 0.65387217 |
100 | RPS6KB2 | 0.64135312 |
101 | FGFR2 | 0.63268553 |
102 | PRKAA1 | 0.61715051 |
103 | MARK3 | 0.60887531 |
104 | PRKCH | 0.60471737 |
105 | CAMKK2 | 0.60345303 |
106 | CHEK1 | 0.60129679 |
107 | PDK3 | 0.59179001 |
108 | PDK4 | 0.59179001 |
109 | MAP2K3 | 0.59165132 |
110 | PLK2 | 0.58400934 |
111 | MAP3K2 | 0.58028468 |
112 | FLT3 | 0.57516560 |
113 | CDK3 | 0.55684741 |
114 | EPHA3 | 0.55007634 |
115 | RAF1 | 0.54930033 |
116 | PDGFRA | 0.54248149 |
117 | PRKCQ | 0.53302995 |
118 | EGFR | 0.52012345 |
119 | STK24 | 0.51944675 |
120 | SGK1 | 0.51734339 |
121 | ATR | 0.51677963 |
122 | MAP3K6 | 0.51192934 |
123 | GRK6 | 0.50484586 |
124 | MAPK10 | 0.50353199 |
125 | PTK2B | 0.48329726 |
126 | SCYL2 | 0.48203060 |
127 | OXSR1 | 0.47018831 |
128 | CAMK4 | 0.46636980 |
129 | FES | 0.45848229 |
130 | IRAK3 | 0.45672545 |
131 | CDK4 | 0.44108997 |
132 | MAPK11 | 0.43993133 |
133 | MAP3K5 | 0.43845627 |
134 | ATM | 0.43749908 |
135 | MARK2 | 0.42676487 |
136 | BMX | 0.41830947 |
137 | MAP2K4 | 0.41325926 |
138 | MELK | 0.41076137 |
139 | PRKACB | 0.40446039 |
140 | PAK3 | 0.39192293 |
141 | FER | 0.37429464 |
142 | FGR | 0.37031617 |
143 | GSK3B | 0.36520024 |
144 | DYRK1A | 0.36059942 |
145 | MAPK7 | 0.35863287 |
146 | PRKG1 | 0.34902148 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.39934871 |
2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.09224500 |
3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.04893282 |
4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.96174326 |
5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.90775689 |
6 | Leishmaniasis_Homo sapiens_hsa05140 | 1.88802161 |
7 | Circadian rhythm_Homo sapiens_hsa04710 | 1.80566303 |
8 | Measles_Homo sapiens_hsa05162 | 1.76775813 |
9 | Lysine degradation_Homo sapiens_hsa00310 | 1.66362048 |
10 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.66091364 |
11 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.60823261 |
12 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.60377010 |
13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.59440361 |
14 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.57541329 |
15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.56227823 |
16 | Influenza A_Homo sapiens_hsa05164 | 1.47446278 |
17 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.46992077 |
18 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.41675960 |
19 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.41551759 |
20 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.40184153 |
21 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.39581273 |
22 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.38572237 |
23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.34083197 |
24 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.30085101 |
25 | Insulin resistance_Homo sapiens_hsa04931 | 1.26504350 |
26 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.26490795 |
27 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.26272244 |
28 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.24090603 |
29 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.23057561 |
30 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.21820262 |
31 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.20106077 |
32 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.18872585 |
33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.17924405 |
34 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.17474656 |
35 | ABC transporters_Homo sapiens_hsa02010 | 1.16772592 |
36 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.15631901 |
37 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.15210334 |
38 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.15207215 |
39 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.15079588 |
40 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.14956575 |
41 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.13971939 |
42 | Hepatitis B_Homo sapiens_hsa05161 | 1.13884806 |
43 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.13098415 |
44 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.11665004 |
45 | Tuberculosis_Homo sapiens_hsa05152 | 1.09748981 |
46 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.09707004 |
47 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.09694762 |
48 | Long-term potentiation_Homo sapiens_hsa04720 | 1.07958626 |
49 | Platelet activation_Homo sapiens_hsa04611 | 1.05704711 |
50 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.04797479 |
51 | Cell cycle_Homo sapiens_hsa04110 | 1.04728931 |
52 | Homologous recombination_Homo sapiens_hsa03440 | 1.03615913 |
53 | Apoptosis_Homo sapiens_hsa04210 | 1.02832762 |
54 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.02301507 |
55 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.01834137 |
56 | Hepatitis C_Homo sapiens_hsa05160 | 1.00373360 |
57 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.98994953 |
58 | Viral myocarditis_Homo sapiens_hsa05416 | 0.98511828 |
59 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.97516746 |
60 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.96827808 |
61 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.96092160 |
62 | Long-term depression_Homo sapiens_hsa04730 | 0.95987476 |
63 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.95571941 |
64 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.94862530 |
65 | Thyroid cancer_Homo sapiens_hsa05216 | 0.93429443 |
66 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.93425310 |
67 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.93237263 |
68 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.92868990 |
69 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.91660632 |
70 | Legionellosis_Homo sapiens_hsa05134 | 0.90821211 |
71 | Pertussis_Homo sapiens_hsa05133 | 0.88359118 |
72 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.85472043 |
73 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.83039839 |
74 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.82759219 |
75 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.82027628 |
76 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.80415224 |
77 | Alcoholism_Homo sapiens_hsa05034 | 0.79889456 |
78 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.79800613 |
79 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.78127058 |
80 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.77616819 |
81 | Malaria_Homo sapiens_hsa05144 | 0.76182025 |
82 | Amoebiasis_Homo sapiens_hsa05146 | 0.75398857 |
83 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.74754629 |
84 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.74684640 |
85 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.74595739 |
86 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.74544439 |
87 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.73961308 |
88 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.73567170 |
89 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.73428017 |
90 | Basal transcription factors_Homo sapiens_hsa03022 | 0.72746471 |
91 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.71261553 |
92 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.71203159 |
93 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.70937948 |
94 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.70909167 |
95 | Prostate cancer_Homo sapiens_hsa05215 | 0.70271087 |
96 | Salmonella infection_Homo sapiens_hsa05132 | 0.69909370 |
97 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.69598988 |
98 | Glioma_Homo sapiens_hsa05214 | 0.69002350 |
99 | Endometrial cancer_Homo sapiens_hsa05213 | 0.68420421 |
100 | Melanoma_Homo sapiens_hsa05218 | 0.66961053 |
101 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.66624157 |
102 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.66406965 |
103 | Allograft rejection_Homo sapiens_hsa05330 | 0.66096130 |
104 | Focal adhesion_Homo sapiens_hsa04510 | 0.65616008 |
105 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.65421386 |
106 | Adherens junction_Homo sapiens_hsa04520 | 0.64834486 |
107 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.64203670 |
108 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.62831321 |
109 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.60056084 |
110 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59771278 |
111 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.59298466 |
112 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.58760880 |
113 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.58166170 |
114 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.57355061 |
115 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.56955211 |
116 | HTLV-I infection_Homo sapiens_hsa05166 | 0.54138750 |
117 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.53918625 |
118 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.53463036 |
119 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.52164064 |
120 | Taste transduction_Homo sapiens_hsa04742 | 0.51450870 |
121 | RNA transport_Homo sapiens_hsa03013 | 0.51103615 |
122 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.49927715 |
123 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.49738657 |
124 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.48823324 |
125 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.48715100 |
126 | Shigellosis_Homo sapiens_hsa05131 | 0.48230071 |
127 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.48158345 |
128 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.48144892 |
129 | Renin secretion_Homo sapiens_hsa04924 | 0.47718841 |
130 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.47553157 |
131 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.47499559 |
132 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.42786031 |
133 | Colorectal cancer_Homo sapiens_hsa05210 | 0.42586502 |